Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Pediatrix Medical (MD)

Pediatrix Q3 revenue rises 1.7% to $501 million; GAAP net income falls to $47 million

Mixed Impact 3 of 5 earnings

Pediatrix Medical Group reported third-quarter 2026 net revenue of $501.4 million, up 1.7% from $492.9 million a year earlier, and adjusted EPS of $0.72 versus $0.67. GAAP net income fell to $47.0 million, or $0.59 per diluted share, from $71.7 million, or $0.84, and adjusted EBITDA declined to $85.5 million from $87.3 million. The company also projects full-year 2026 adjusted EBITDA of $290 million to $300 million.

Key points

  • Q3 net revenue $501.4 million vs. $492.9 million in Q3 2025, up 1.7%
  • Q3 net income $47.0 million ($0.59 diluted EPS) vs. $71.7 million ($0.84), including a $20.9 million investment gain in the prior-year quarter
  • Q3 adjusted EPS $0.72 vs. $0.67; adjusted EBITDA $85.5 million vs. $87.3 million
  • Full-year 2026 adjusted EBITDA outlook of $290 million to $300 million

The filing

CompanyPediatrix Medical (MD)
Form8-K, current report
Filed with the SECOct 29, 2026, 6:50 AM ET
Accession number0001193125-26-436932

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 7, 2026, 11:18 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.